Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(9):685-686; doi:10.1093/jnci/92.9.685
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Fintor, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fintor, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 9, 685-686, May 3, 2000
© 2000 Oxford University Press

NEWS

Brain Tumor Research Facility Debuts in Montreal

Lou Fintor

The world’s first freestanding state-of-the-art brain tumor research facility will be dedicated this fall in Montreal. The new Can$26 million (about US $18 million) Montreal Brain Tumour Research Centre, an integral part of McGill University’s Montreal Neurological Institute and the 135-bed Montreal Neurological Hospital, will concentrate on brain tumor diagnosis, treatment, and research.



View larger version (131K):
[in this window]
[in a new window]
  		The Montreal Brain Tumour Research Centre will concentrate on brain tumor diagnosis, treatment, and research.

 
MNI Director Richard Murphy, Ph.D., said that "our challenge has been to create a critical mass of people and to create a center of strength that can be a worldwide . . . [Full Text of this Article]

State-of-the-Art Facility

Tumor Genetics

Neuroanatomy Effort


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?